Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2026, Vol. 31 ›› Issue (8): 1127-1134.doi: 10.12092/j.issn.1009-2501.2026.08.013

Previous Articles    

Advances in the construction and application of animal models for diabetic macrovascular complications

Yujie YANG1,2(), Lili ZHANG1,2, Xinyun PAN1,2, Yingpeng DING3,*(), Zhongqun WANG1,2,*()   

  1. 1. Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang 212000, Jiangsu, China
    2. Institute of Cardiovascular Diseases, Jiangsu University, Zhenjiang 212001, Jiangsu, China
    3. Department of Cardiology, Changzhou Jintan First People's Hospital, Changzhou 213200, Jiangsu, China
  • Received:2025-12-14 Revised:2026-02-08 Online:2026-08-26 Published:2026-09-09
  • Contact: Yingpeng DING,Zhongqun WANG E-mail:1328044834@qq.com;doctording0556@163.com;wangtsmc@126.com

Abstract:

Diabetes-associated macrovascular complications constitute a principal source of disability and mortality among individuals with diabetes. The defining pathological hallmark of these complications is the accelerated development of atherosclerosis accompanied by heightened plaque instability, arising in the context of chronic metabolic dysregulation. Animal models are therefore indispensable for elucidating the underlying mechanisms of diabetic macrovascular disease and for rigorously assessing preventive and therapeutic interventions. This review concentrates on the major manifestations of diabetic macrovascular pathology, including coronary artery disease, cerebrovascular disease, and peripheral arterial disease. It provides a systematic synthesis of the construction strategies, pathological features, and current research applications of widely used animal models, encompassing diet-induced, chemically induced, genetically modified, and combined-intervention approaches. In addition, the review offers a comparative evaluation of these models with respect to their capacity to recapitulate disease phenotypes and their suitability for addressing specific research questions, while also critically examining their methodological limitations. Collectively, this work aims to inform the rational selection and refinement of animal models for the study of diabetic macrovascular complications.

Key words: diabetes-associated macrovascular complications, atherosclerosis, animal model

CLC Number: